|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jochems C and Schlom J: Tumor-infiltrating
immune cells and prognosis: The potential link between conventional
cancer therapy and immunity. Exp Biol Med (Maywood). 236:567–579.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu K, Yang K, Wu B, Chen H, Chen X, Chen
X, Jiang L, Ye F, He D and Lu Z: Tumor-infiltrating immune cells
are associated with prognosis of gastric cancer. Medicine
(Baltimore). 94:e16312015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Noy R and Pollard JW: Tumor-associated
macrophages: From mechanisms to therapy. Immunity. 41:49–61. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim J and Bae JS: Tumor-associated
macrophages and neutrophils in tumor microenvironment. Mediators
Inflamm. 2016:60581472016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yin S, Huang J, Li Z, Zhang J, Luo J, Lu C
and Xu H and Xu H: The prognostic and clinicopathological
significance of tumor-associated macrophages in patients with
gastric cancer: A meta-analysis. PLoS One. 12:e01700422017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Biswas SK, Allavena P and Mantovani A:
Tumor-associated macrophages: Functional diversity, clinical
significance, and open questions. Semin Immunopathol. 35:585–600.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mantovani A, Marchesi F, Malesci A, Laghi
L and Allavena P: Tumour-associated macrophages as treatment
targets in oncology. Nat Rev Clin Oncol. 14:399–416. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Medrek C, Pontén F, Jirström K and
Leandersson K: The presence of tumor associated macrophages in
tumor stroma as a prognostic marker for breast cancer patients. BMC
Cancer. 12:3062012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mei J, Xiao Z, Guo C, Pu Q, Ma L, Liu C,
Lin F, Liao H, You Z and Liu L: Prognostic impact of
tumor-associated macrophage infiltration in non-small cell lung
cancer: A systemic review and meta-analysis. Oncotarget.
7:34217–34228. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ryder M, Ghossein RA, Ricarte-Filho JC,
Knauf JA and Fagin JA: Increased density of tumor-associated
macrophages is associated with decreased survival in advanced
thyroid cancer. Endocr Relat Cancer. 15:1069–1074. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sugimura K, Miyata H, Tanaka K, Takahashi
T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M and Doki
Y: High infiltration of tumor-associated macrophages is associated
with a poor response to chemotherapy and poor prognosis of patients
undergoing neoadjuvant chemotherapy for esophageal cancer. J Surg
Oncol. 111:752–759. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yuan X, Zhang J, Li D, Mao Y, Mo F, Du W
and Ma X: Prognostic significance of tumor-associated macrophages
in ovarian cancer: A meta-analysis. Gynecol Oncol. 147:181–187.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun Y and Xu S: Tumor-associated
CD204-positive macrophage is a prognostic marker in clinical stage
I lung adenocarcinoma. Biomed Res Int. 2018:84591932018.PubMed/NCBI
|
|
16
|
Ren CX, Leng RX, Fan YG, Pan HF, Li BZ, Wu
CH, Wu Q, Wang NN, Xiong QR, Geng XP and Ye DQ: Intratumoral and
peritumoral expression of CD68 and CD206 in hepatocellular
carcinoma and their prognostic value. Oncol Rep. 38:886–898. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park JY, Sung JY, Lee J, Park YK, Kim YW,
Kim GY, Won KY and Lim SJ: Polarized CD163+
tumor-associated macrophages are associated with increased
angiogenesis and CXCL12 expression in gastric cancer. Clin Res
Hepatol Gastroenterol. 40:357–365. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ichimura T, Abe H, Morikawa T, Yamashita
H, Ishikawa S, Ushiku T, Seto Y and Fukayama M: Low density of
CD204- positive M2-type tumor-associated macrophages in
Epstein-Barr virus-associated gastric cancer: A clinicopathologic
study with digital image analysis. Hum Pathol. 56:74–80. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Riabov V, Yin S, Song B, Avdic A,
Schledzewski K, Ovsiy I, Gratchev A, Llopis Verdiell M, Sticht C,
Schmuttermaier C, et al: Stabilin-1 is expressed in human breast
cancer and supports tumor growth in mammary adenocarcinoma mouse
model. Oncotarget. 7:31097–31110. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
David C, Nance JP, Hubbard J, Hsu M,
Binder D and Wilson EH: Stabilin-1 expression in tumor associated
macrophages. Brain Res. 1481:71–78. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karikoski M, Marttila-Ichihara F, Elima K,
Rantakari P, Hollmén M, Kelkka T, Gerke H, Huovinen V, Irjala H,
Holmdahl R, et al: Clever-1/stabilin-1 controls cancer growth and
metastasis. Clin Cancer Res. 20:6452–6464. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schledzewski K, Falkowski M, Moldenhauer
G, Metharom P, Kzhyshkowska J, Ganss R, Demory A, Falkowska-Hansen
B, Kurzen H, Ugurel S, et al: Lymphatic endothelium-specific
hyaluronan receptor LYVE-1 is expressed by stabilin-1+,
F4/80+, CD11b+ macrophages in malignant
tumours and wound healing tissue in vivo and in bone marrow
cultures in vitro: Implications for the assessment of
lymphangiogenesis. J Pathol. 209:67–77. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Algars A, Irjala H, Vaittinen S, Huhtinen
H, Sundström J, Salmi M, Ristamäki R and Jalkanen S: Type and
location of tumor-infiltrating macrophages and lymphatic vessels
predict survival of colorectal cancer patients. Int J Cancer.
311:864–873. 2012. View Article : Google Scholar
|
|
24
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual, 7th edition.
Springer-Verlag; New York: pp. 117–26. 2009
|
|
25
|
Kzhyshkowska J: Multifunctional receptor
stabilin-1 in homeostasis and disease. ScientificWorldJournal.
10:2039–2053. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Harada K, Dong X, Estrella JS, Correa AM,
Xu Y, Hofstetter WL, Sudo K, Onodera H, Suzuki K, Suzuki A, et al:
Tumor-associated macrophage infiltration is highly associated with
PD-L1 expression in gastric adenocarcinoma. Gastric Cancer.
21:31–40. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pantano F, Berti P, Guida FM, Perrone G,
Vincenzi B, Amato MM, Righi D, Dell'aquila E, Graziano F, Catalano
V, et al: The role of macrophages polarization in predicting
prognosis of radically resected gastric cancer patients. J Cell Mol
Med. 17:1415–1421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kzhyshkowska J, Workman G, Cardó-Vila M,
Arap W, Pasqualini R, Gratchev A, Krusell L, Goerdt S and Sage EH:
Novel function of alternatively activated macrophages:
Stabilin-1-mediated clearance of SPARC. J Immunol. 176:5825–5832.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schönhaar K, Schledzewski K, Michel J,
Dollt C, Gkaniatsou C, Géraud C, Kzhyshkowska J, Goerdt S and
Schmieder A: Expression of stabilin-1 in M2 macrophages in human
granulomatous disease and melanocytic lesions. Int J Clin Exp
Pathol. 7:1625–1634. 2014.PubMed/NCBI
|
|
30
|
Zhao ZS, Wang YY, Chu YQ, Ye ZY and Tao
HQ: SPARC is associated with gastric cancer progression and poor
survival of patients. Clin Cancer Res. 16:260–268. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Z, Li AD, Xu L, Bai DW, Hou KZ, Zheng
HC, Qu XJ and Liu YP: SPARC expression in gastric cancer predicts
poor prognosis: Results from a clinical cohort, pooled analysis and
GSEA assay. Oncotarget. 7:70211–70222. 2016.PubMed/NCBI
|
|
32
|
Franke K, Carl-McGrath S, Röhl FW,
Lendeckel U, Ebert MP, Tänzer M, Pross M and Röcken C: Differential
expression of SPARC in intestinal-type gastric cancer correlates
with tumor progression and nodal spread. Transl Oncol. 2:310–320.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang L, Yang M, Shan L, Qi L, Chai C, Zhou
Q, Yao K, Wu H and Sun W: The role of SPARC protein expression in
the progress of gastric cancer. Pathol Oncol Res. 18:697–702. 2012.
View Article : Google Scholar : PubMed/NCBI
|
